SCHEMBL6350876

SCHEMBL6350876

COC(=O)C(Oc1ccc(C(=O)Nc2ccc(Br)cc2C(=O)O)cc1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT3A Q9Y6K1 1/20 0.53
AKR1C2 P52895 3/20 0.52
AKR1C1 Q04828 3/20 0.52
MAPT P10636 4/20 0.51
AKR1C4 P17516 1/20 0.51
AKR1C3 P42330 1/20 0.51
DHODH Q02127 1/20 0.50
KCNK2 O95069 1/20 0.49
KCNK10 P57789 1/20 0.49
SERPINE1 P05121 1/20 0.48
IGF2BP2 Q9Y6M1 1/20 0.46
ALDH1A1 P00352 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 1/20 0.46
ABL1 P00519 1/20 0.46
TSHR P16473 1/20 0.46
KMT2A Q03164 1/20 0.46
RIN1 Q13671 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6353697 0.91 AKR1C2 (0.64) DNMT3AAKR1C2AKR1C1MAPTAKR1C4
SCHEMBL6353698 0.82 KCNK2 (0.57) DNMT3AAKR1C2AKR1C1MAPTAKR1C4
SCHEMBL6349859 0.81 MAPT (0.76) AKR1C2AKR1C1MAPTAKR1C4AKR1C3
SCHEMBL6352030 0.80 KCNK2 (0.60) DNMT3AAKR1C2AKR1C1MAPTAKR1C4
SCHEMBL6353723 0.80 AKR1C2 (0.55) DNMT3AAKR1C2AKR1C1MAPTAKR1C4
SCHEMBL20512990 0.78 SERPINE1 (0.66) AKR1C2AKR1C1MAPTAKR1C4AKR1C3
SCHEMBL9513479 0.78 MAPT (0.80) AKR1C2AKR1C1MAPTAKR1C4AKR1C3
SCHEMBL17166275 0.78 AKR1C2 (0.73) AKR1C2AKR1C1MAPTAKR1C4AKR1C3
SCHEMBL6350824 0.77 KCNK2 (0.62) AKR1C2AKR1C1MAPTAKR1C4AKR1C3
SCHEMBL6349385 0.77 AKR1C2 (0.71) AKR1C2AKR1C1MAPTAKR1C4AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 DNMT3A 1184/4885AKR1C2 3012/4885AKR1C1 2615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.